| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0378 |
Hospital observation service, per hour |
2,685 |
840 |
$971K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,374 |
4,781 |
$704K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,172 |
3,666 |
$686K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,888 |
1,422 |
$562K |
| 80053 |
Comprehensive metabolic panel |
6,049 |
4,662 |
$478K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,303 |
5,456 |
$470K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
546 |
454 |
$380K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,155 |
2,443 |
$321K |
| 84484 |
|
2,905 |
1,901 |
$309K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,495 |
2,746 |
$259K |
| 36415 |
Collection of venous blood by venipuncture |
3,603 |
2,318 |
$258K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,259 |
1,119 |
$246K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,535 |
1,883 |
$231K |
| 93017 |
|
374 |
267 |
$223K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,036 |
1,490 |
$220K |
| 83735 |
|
2,912 |
2,092 |
$218K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
248 |
166 |
$200K |
| 71045 |
Radiologic examination, chest; single view |
2,009 |
1,589 |
$197K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,248 |
1,525 |
$190K |
| 82550 |
|
1,563 |
981 |
$190K |
| 81025 |
|
1,632 |
1,368 |
$172K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,109 |
976 |
$171K |
| 71046 |
Radiologic examination, chest; 2 views |
1,752 |
1,517 |
$151K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,505 |
1,390 |
$150K |
| 81001 |
|
2,388 |
2,079 |
$139K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,970 |
1,831 |
$136K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,391 |
1,131 |
$121K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,644 |
1,404 |
$114K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,300 |
578 |
$111K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
225 |
153 |
$111K |
| 85730 |
|
1,350 |
1,107 |
$108K |
| 83690 |
|
1,618 |
1,336 |
$104K |
| 85610 |
|
1,557 |
1,231 |
$102K |
| 82553 |
|
834 |
656 |
$97K |
| 83880 |
|
797 |
628 |
$96K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,318 |
508 |
$94K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
869 |
734 |
$91K |
| 85027 |
|
1,153 |
776 |
$90K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
128 |
108 |
$86K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
379 |
211 |
$85K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
313 |
281 |
$79K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,091 |
904 |
$78K |
| J2785 |
Injection, regadenoson, 0.1 mg |
132 |
85 |
$70K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
492 |
345 |
$70K |
| 82150 |
|
1,095 |
915 |
$68K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
312 |
281 |
$66K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
238 |
131 |
$63K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
481 |
296 |
$60K |
| 87040 |
|
772 |
622 |
$57K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
322 |
253 |
$54K |
| 87070 |
|
867 |
744 |
$54K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,557 |
399 |
$54K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
548 |
285 |
$53K |
| 81003 |
|
624 |
518 |
$52K |
| 83605 |
|
767 |
595 |
$51K |
| 80061 |
Lipid panel |
431 |
312 |
$51K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
424 |
284 |
$47K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
510 |
391 |
$44K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
925 |
652 |
$41K |
| 87077 |
|
703 |
595 |
$40K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
219 |
168 |
$38K |
| 85379 |
|
439 |
354 |
$37K |
| 73630 |
|
299 |
275 |
$37K |
| 87186 |
|
667 |
564 |
$33K |
| 82248 |
|
653 |
563 |
$32K |
| 73130 |
|
231 |
209 |
$32K |
| 73610 |
|
254 |
226 |
$32K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
300 |
239 |
$31K |
| J3490 |
Unclassified drugs |
245 |
142 |
$31K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
510 |
341 |
$29K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
165 |
123 |
$26K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
658 |
198 |
$26K |
| 73564 |
|
176 |
166 |
$26K |
| 82746 |
|
381 |
328 |
$25K |
| 73030 |
|
198 |
180 |
$24K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
55 |
45 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
338 |
310 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
249 |
176 |
$20K |
| 84439 |
|
326 |
299 |
$19K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
106 |
37 |
$18K |
| 85652 |
|
193 |
144 |
$17K |
| 97014 |
|
389 |
122 |
$16K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
282 |
205 |
$14K |
| 82607 |
|
210 |
178 |
$14K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
122 |
94 |
$13K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
38 |
17 |
$13K |
| 70486 |
|
57 |
55 |
$13K |
| 87205 |
|
225 |
187 |
$13K |
| 93971 |
|
29 |
28 |
$13K |
| 84436 |
|
195 |
170 |
$12K |
| 73110 |
|
84 |
72 |
$12K |
| 88342 |
|
31 |
12 |
$11K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
152 |
132 |
$11K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
151 |
131 |
$11K |
| 84702 |
|
87 |
67 |
$10K |
| 87420 |
|
136 |
118 |
$10K |
| 71250 |
|
33 |
28 |
$10K |
| 97162 |
|
41 |
26 |
$10K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
51 |
44 |
$9K |
| 97161 |
|
156 |
136 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
73 |
44 |
$8K |
| 74022 |
|
68 |
67 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
31 |
26 |
$5K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
64 |
54 |
$5K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
61 |
51 |
$5K |
| 82803 |
|
18 |
12 |
$5K |
| 36600 |
|
18 |
12 |
$5K |
| 86901 |
|
82 |
64 |
$5K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
70 |
51 |
$4K |
| 86850 |
|
78 |
63 |
$4K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
37 |
32 |
$3K |
| 96376 |
|
80 |
55 |
$3K |
| 83540 |
|
49 |
46 |
$3K |
| 82728 |
|
45 |
41 |
$3K |
| 73080 |
|
16 |
12 |
$3K |
| 86900 |
|
74 |
51 |
$2K |
| 83550 |
|
31 |
29 |
$2K |
| 73502 |
|
12 |
12 |
$2K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
25 |
24 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
20 |
13 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
17 |
12 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
17 |
12 |
$1K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
56 |
12 |
$1K |
| 74019 |
|
28 |
25 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
27 |
27 |
$1K |
| 97166 |
|
27 |
26 |
$883.83 |
| V2630 |
Anterior chamber intraocular lens |
14 |
13 |
$839.09 |
| 87430 |
|
12 |
12 |
$700.86 |
| 82009 |
|
13 |
12 |
$525.90 |
| 73090 |
|
16 |
15 |
$469.10 |
| 86140 |
|
31 |
28 |
$376.21 |
| A9270 |
Non-covered item or service |
5,564 |
835 |
$251.55 |
| 73590 |
|
14 |
12 |
$163.25 |